2024-04-012025-03-312025-03-31false09515416ORAL HEALTHCARE LIMITED2025-06-27falseiso4217:GBPxbrli:pure095154162024-03-31095154162025-03-31095154162024-04-012025-03-31095154162023-03-31095154162024-03-31095154162023-04-012024-03-3109515416bus:SmallEntities2024-04-012025-03-3109515416bus:AuditExempt-NoAccountantsReport2024-04-012025-03-3109515416bus:FullAccounts2024-04-012025-03-3109515416bus:PrivateLimitedCompanyLtd2024-04-012025-03-3109515416core:WithinOneYear2025-03-3109515416core:AfterOneYear2025-03-3109515416core:WithinOneYear2024-03-3109515416core:AfterOneYear2024-03-3109515416core:ShareCapital2025-03-3109515416core:SharePremium2025-03-3109515416core:RevaluationReserve2025-03-3109515416core:OtherReservesSubtotal2025-03-3109515416core:RetainedEarningsAccumulatedLosses2025-03-3109515416core:ShareCapital2024-03-3109515416core:SharePremium2024-03-3109515416core:RevaluationReserve2024-03-3109515416core:OtherReservesSubtotal2024-03-3109515416core:RetainedEarningsAccumulatedLosses2024-03-3109515416core:LandBuildings2025-03-3109515416core:PlantMachinery2025-03-3109515416core:Vehicles2025-03-3109515416core:FurnitureFittings2025-03-3109515416core:OfficeEquipment2025-03-3109515416core:NetGoodwill2025-03-3109515416core:IntangibleAssetsOtherThanGoodwill2025-03-3109515416core:ListedExchangeTraded2025-03-3109515416core:UnlistedNon-exchangeTraded2025-03-3109515416core:LandBuildings2024-03-3109515416core:PlantMachinery2024-03-3109515416core:Vehicles2024-03-3109515416core:FurnitureFittings2024-03-3109515416core:OfficeEquipment2024-03-3109515416core:NetGoodwill2024-03-3109515416core:IntangibleAssetsOtherThanGoodwill2024-03-3109515416core:ListedExchangeTraded2024-03-3109515416core:UnlistedNon-exchangeTraded2024-03-3109515416core:LandBuildings2024-04-012025-03-3109515416core:PlantMachinery2024-04-012025-03-3109515416core:Vehicles2024-04-012025-03-3109515416core:FurnitureFittings2024-04-012025-03-3109515416core:OfficeEquipment2024-04-012025-03-3109515416core:NetGoodwill2024-04-012025-03-3109515416core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3109515416core:ListedExchangeTraded2024-04-012025-03-3109515416core:UnlistedNon-exchangeTraded2024-04-012025-03-3109515416core:MoreThanFiveYears2024-04-012025-03-3109515416core:Non-currentFinancialInstruments2025-03-3109515416core:Non-currentFinancialInstruments2024-03-3109515416dpl:CostSales2024-04-012025-03-3109515416dpl:DistributionCosts2024-04-012025-03-3109515416core:LandBuildings2024-04-012025-03-3109515416core:PlantMachinery2024-04-012025-03-3109515416core:Vehicles2024-04-012025-03-3109515416core:FurnitureFittings2024-04-012025-03-3109515416core:OfficeEquipment2024-04-012025-03-3109515416dpl:AdministrativeExpenses2024-04-012025-03-3109515416core:NetGoodwill2024-04-012025-03-3109515416core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3109515416dpl:GroupUndertakings2024-04-012025-03-3109515416dpl:ParticipatingInterests2024-04-012025-03-3109515416dpl:GroupUndertakingscore:ListedExchangeTraded2024-04-012025-03-3109515416core:ListedExchangeTraded2024-04-012025-03-3109515416dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-04-012025-03-3109515416core:UnlistedNon-exchangeTraded2024-04-012025-03-3109515416dpl:CostSales2023-04-012024-03-3109515416dpl:DistributionCosts2023-04-012024-03-3109515416core:LandBuildings2023-04-012024-03-3109515416core:PlantMachinery2023-04-012024-03-3109515416core:Vehicles2023-04-012024-03-3109515416core:FurnitureFittings2023-04-012024-03-3109515416core:OfficeEquipment2023-04-012024-03-3109515416dpl:AdministrativeExpenses2023-04-012024-03-3109515416core:NetGoodwill2023-04-012024-03-3109515416core:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3109515416dpl:GroupUndertakings2023-04-012024-03-3109515416dpl:ParticipatingInterests2023-04-012024-03-3109515416dpl:GroupUndertakingscore:ListedExchangeTraded2023-04-012024-03-3109515416core:ListedExchangeTraded2023-04-012024-03-3109515416dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-04-012024-03-3109515416core:UnlistedNon-exchangeTraded2023-04-012024-03-3109515416core:NetGoodwill2025-03-3109515416core:IntangibleAssetsOtherThanGoodwill2025-03-3109515416core:LandBuildings2025-03-3109515416core:PlantMachinery2025-03-3109515416core:Vehicles2025-03-3109515416core:FurnitureFittings2025-03-3109515416core:OfficeEquipment2025-03-3109515416core:AfterOneYear2025-03-3109515416core:WithinOneYear2025-03-3109515416core:ListedExchangeTraded2025-03-3109515416core:UnlistedNon-exchangeTraded2025-03-3109515416core:ShareCapital2025-03-3109515416core:SharePremium2025-03-3109515416core:RevaluationReserve2025-03-3109515416core:OtherReservesSubtotal2025-03-3109515416core:RetainedEarningsAccumulatedLosses2025-03-3109515416core:NetGoodwill2024-03-3109515416core:IntangibleAssetsOtherThanGoodwill2024-03-3109515416core:LandBuildings2024-03-3109515416core:PlantMachinery2024-03-3109515416core:Vehicles2024-03-3109515416core:FurnitureFittings2024-03-3109515416core:OfficeEquipment2024-03-3109515416core:AfterOneYear2024-03-3109515416core:WithinOneYear2024-03-3109515416core:ListedExchangeTraded2024-03-3109515416core:UnlistedNon-exchangeTraded2024-03-3109515416core:ShareCapital2024-03-3109515416core:SharePremium2024-03-3109515416core:RevaluationReserve2024-03-3109515416core:OtherReservesSubtotal2024-03-3109515416core:RetainedEarningsAccumulatedLosses2024-03-3109515416core:NetGoodwill2023-03-3109515416core:IntangibleAssetsOtherThanGoodwill2023-03-3109515416core:LandBuildings2023-03-3109515416core:PlantMachinery2023-03-3109515416core:Vehicles2023-03-3109515416core:FurnitureFittings2023-03-3109515416core:OfficeEquipment2023-03-3109515416core:AfterOneYear2023-03-3109515416core:WithinOneYear2023-03-3109515416core:ListedExchangeTraded2023-03-3109515416core:UnlistedNon-exchangeTraded2023-03-3109515416core:ShareCapital2023-03-3109515416core:SharePremium2023-03-3109515416core:RevaluationReserve2023-03-3109515416core:OtherReservesSubtotal2023-03-3109515416core:RetainedEarningsAccumulatedLosses2023-03-3109515416core:AfterOneYear2024-04-012025-03-3109515416core:WithinOneYear2024-04-012025-03-3109515416core:Non-currentFinancialInstrumentscore:CostValuation2024-04-012025-03-3109515416core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-04-012025-03-3109515416core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-04-012025-03-3109515416core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-04-012025-03-3109515416core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-04-012025-03-3109515416core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-04-012025-03-3109515416core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3109515416core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3109515416core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3109515416core:Non-currentFinancialInstrumentscore:CostValuation2025-03-3109515416core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-03-3109515416core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-03-3109515416core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-03-3109515416core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-03-3109515416core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-03-3109515416core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-03-3109515416core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-03-3109515416core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-03-3109515416core:Non-currentFinancialInstrumentscore:CostValuation2024-03-3109515416core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-03-3109515416core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-03-3109515416core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-03-3109515416core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-03-3109515416core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-03-3109515416core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-03-3109515416core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-03-3109515416core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-03-3109515416bus:Director12024-04-012025-03-3109515416core:FurnitureFittingsToolsEquipment2024-03-3109515416core:FurnitureFittingsToolsEquipment2025-03-3109515416core:FurnitureFittingsToolsEquipment2024-04-012025-03-31

ORAL HEALTHCARE LIMITED

Registered Number
09515416
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2025

ORAL HEALTHCARE LIMITED
Company Information
for the year from 1 April 2024 to 31 March 2025

Director

PATEL, Sundeep

Registered Address

74 Pentland Road
Slough
SL2 1TN

Registered Number

09515416 (England and Wales)
ORAL HEALTHCARE LIMITED
Balance Sheet as at
31 March 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Intangible assets3-19,750
Tangible assets411,25754,620
11,25774,370
Current assets
Debtors561,813285,953
Cash at bank and on hand9,51413,771
571,327299,724
Creditors amounts falling due within one year5(797,735)(399,090)
Net current assets (liabilities)(226,408)(99,366)
Total assets less current liabilities(215,151)(24,996)
Creditors amounts falling due after one year6(22,509)(38,939)
Net assets(237,660)(63,935)
Capital and reserves
Profit and loss account(237,660)(63,935)
Shareholders' funds(237,660)(63,935)
The financial statements were approved and authorised for issue by the Director on 27 June 2025, and are signed on its behalf by:
PATEL, Sundeep
Director
Registered Company No. 09515416
ORAL HEALTHCARE LIMITED
Notes to the Financial Statements
for the year ended 31 March 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Going concern
After reviewing the company's forecasts and projections, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis of accounting in preparing its financial statements.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.
Revenue from sale of goods
Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.
Employee benefits
Contributions to defined contribution plans are expensed in the period to which they relate.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Intangible assets
Intangible assets have been recognised with a useful economic life of 10 years and amortised over their useful economic life.
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows: Fixtures and Fittings - 25% Straight Line Method.
Finance leases and hire purchase contracts
Assets held under finance leases which are leases where substantially all the risks and rewards of ownership of the asset have passed to the company, and hire purchase contracts are capitalised in the balance sheet. They are depreciated over the shorter of their useful lives or the term of the lease.
Related parties
For the purposes of these financial statements, a related party could be a person or an entity. Careful consideration is given to the definition of a related party to ensure that all related party relationships, transactions and balances are identified.
2.Average number of employees

20252024
Average number of employees during the year06
3.Intangible assets

Other

Total

££
Cost or valuation
At 01 April 24197,500197,500
At 31 March 25197,500197,500
Amortisation and impairment
At 01 April 24177,750177,750
Charge for year19,75019,750
At 31 March 25197,500197,500
Net book value
At 31 March 25--
At 31 March 2419,75019,750
4.Tangible fixed assets

Fixtures & fittings

Total

££
Cost or valuation
At 01 April 24173,452173,452
At 31 March 25173,452173,452
Depreciation and impairment
At 01 April 24118,832118,832
Charge for year43,36343,363
At 31 March 25162,195162,195
Net book value
At 31 March 2511,25711,257
At 31 March 2454,62054,620
5.Creditors: amounts due within one year

2025

2024

££
Trade creditors / trade payables355,581323,311
Amounts owed to related parties24,512-
Finance lease and HP contracts15,50427,907
Other creditors402,13847,872
Total797,735399,090
6.Creditors: amounts due after one year

2025

2024

££
Other creditors22,50938,939
Total22,50938,939
7.Obligations under finance leases

2025

2024

££
Finance lease and HP contracts18,45434,884
8.Related party transactions
Included within the Creditors due within one year is balances owed to Director of £241,271 (2023: £200,738).